drugset / Trial / NCT01395030

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

NCT01395030

NaSingle-groupOpen-labelDiagnostic

Summary

This clinical trial studies positron emission tomography (PET)/computed tomography (CT) in diagnosing patients with liver cancer undergoing surgical resection. Diagnostic procedures, such as fluorine-18 fluoromethylcholine PET/CT, may help find and diagnose liver cancer.

Timeline

Start
2011-08-15
Primary completion
2017-05-31
Completion
2018-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorocholine Diagnostic / imaging agent